Back to Results
First PageMeta Content
Medicine / Atypical antipsychotics / Bipolar spectrum / Abnormal psychology / Piperazines / Montgomery-Åsberg Depression Rating Scale / Olanzapine / Antipsychotic / Paroxetine / Emotion / Psychiatry / Mood disorders


Szegedi et al. BMC Psychiatry 2011, 11:101 http://www.biomedcentral.com/1471-244X[removed]
Add to Reading List

Open Document

File Size: 599,66 KB

Share Result on Facebook

City

Rating Scale / /

Company

Pearson / BP / Merck Research Laboratories / BioMed Central Ltd. / Creative Commons / /

Country

Romania / Turkey / Malaysia / Russia / United States / Bulgaria / Philippines / Ukraine / South Korea / India / /

/

Event

Product Recall / Product Issues / /

IndustryTerm

investigative site / treatment of depressive episodes associated with bipolar disorder / /

MedicalCondition

Scale (PANSS) Marder anxiety/depression / schizophrenia / bipolar depression / PANSS Marder anxiety/depression / acute bipolar depression / serious chronic medical condition / Bipolar Disorder-Depression / mania / baseline† PANSS Marder anxiety/depression / bipolar affective disorders / disorder / depression / PANSS Marder anxiety/ depression / acute mania / Mental Disorders / bipolar disorder / /

MedicalTreatment

adjunctive therapy / /

Organization

World Health Organization / European Union / /

Position

author / /

Product

olanzapine / fluoxetine / consent with asenapine / consent with placebo / BP / /

PublishedMedium

Baseline / /

Technology

CGI / /

URL

http /

SocialTag